• 0 Citations
  • 0 h-Index
20182018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where stefania orini is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Differential Diagnosis Medicine & Life Sciences
Primary Progressive Aphasia Medicine & Life Sciences
Dementia Medicine & Life Sciences
Frontotemporal Lobar Degeneration Medicine & Life Sciences
Lewy Body Disease Medicine & Life Sciences
Neurodegenerative Diseases Medicine & Life Sciences
Alzheimer Disease Medicine & Life Sciences
Fluorodeoxyglucose F18 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2018 2018

Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia

EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1470-1486 17 p.

Research output: Contribution to journalReview article

Dementia
Gold
Neurodegenerative Diseases
Population
Decision Making

Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders

EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1557-1566 10 p.

Research output: Contribution to journalReview article

Neurodegenerative Diseases
Differential Diagnosis
Nuclear Medicine
Brain
Autopsy

Clinical utility of FDG-PET for the clinical diagnosis in MCI

EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1497-1508 12 p.

Research output: Contribution to journalReview article

Frontotemporal Lobar Degeneration
Lewy Body Disease
Alzheimer Disease
Cognitive Dysfunction
Fluorodeoxyglucose F18

Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia

EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1509-1525 17 p.

Research output: Contribution to journalReview article

Frontotemporal Lobar Degeneration
Lewy Body Disease
Factitious Disorders
Dementia
Vascular Dementia

Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease

EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1546-1556 11 p.

Research output: Contribution to journalReview article

Huntington Disease
Amyotrophic Lateral Sclerosis
Neurodegenerative Diseases
Biomarkers
Mutation